An accelerated mouse model for atherosclerosis and adipose tissue inflammation

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Neuhofer, Angelika ^a   Wernly, Bernhard ^a   Leitner, Lukas ^a   Sarabi, Alisina ^a   Sommer, Nicole G ^a   Staffler, Günther ^b   Zeyda, Maximilian ^a   Stulnig, Thomas M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AFFiRiS GmbH   (Austria)

Author keywords

Adipose tissue inflammation; Atherosclerosis; Cardio metabolic disease; Diet induced obesity; Glucose intolerance; Insulin resistance; Metabolic syndrome; Sucrose enrichment; Type 2 diabetes

Indexed keywords

CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SUCROSE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; FEEDING; GENE EXPRESSION; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OBESITY;

ADIPOSE TISSUE; ANIMALS; ATHEROSCLEROSIS; DIETARY FATS; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; TIME FACTORS;

EID: 84892466805     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-23     Document Type: Article

References (57)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654.
2. Bornfeldt K, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 2011, 14(5):575-585. 10.1016/j.cmet.2011.07.015, 3217209, 22055501.
3. An X, Yu D, Zhang R, Zhu J, Du R, Shi Y, Xiong X. Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study. Cardiovasc Diabetol 2012, 11:71. 10.1186/1475-2840-11-71, 3441242, 22709409.
4. O'Rourke R. Inflammation in obesity-related diseases. Surgery 2009, 145(3):255-259. 10.1016/j.surg.2008.08.038, 2749322, 19231576.
5. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006, 444(7121):860-867. 10.1038/nature05485, 17167474.
6. Zeyda M, Stulnig TM. Obesity, inflammation, and insulin resistance-a mini-review. Gerontology 2009, 55(4):379-386. 10.1159/000212758, 19365105.
7. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012, 18(3):363-374. 10.1038/nm.2627, 22395709.
8. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112(12):1796-1808. 296995, 14679176.
9. Sell H, Eckel J. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care 2010, 13(4):366-370. 10.1097/MCO.0b013e32833aab7f, 20473150.
10. Breyne J, Juthier F, Corseaux D, Marechaux S, Zawadzki C, Jeanpierre E, Ung A, Ennezat PV, Susen S, Van Belle E, et al. Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis 2010, 213(2):369-376. 10.1016/j.atherosclerosis.2010.07.047, 20732681.
11. Yan X, Sano M, Lu L, Wang W, Zhang Q, Zhang R, Wang L, Chen Q, Fukuda K, Shen W. Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2010, 9:70. 10.1186/1475-2840-9-70, 2988001, 21034455.
12. Matsui Y, Rittling SR, Okamoto H, Inobe M, Jia N, Shimizu T, Akino M, Sugawara T, Morimoto J, Kimura C, et al. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23(6):1029-1034. 10.1161/01.ATV.0000074878.29805.D0, 12730087.
13. Bruemmer D, Collins AR, Noh G, Wang W, Territo M, Arias-Magallona S, Fishbein MC, Blaschke F, Kintscher U, Graf K, et al. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 2003, 112(9):1318-1331. 228408, 14597759.
14. Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood E, Jones K, Kawamori R, Cassis L, Tschöp M, et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007, 117(10):2877-2888. 10.1172/JCI31986, 1964510, 17823662.
15. Kiefer F, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T, Säemann M, Geyeregger R, Schlederer M, Kenner L, et al. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 2010, 59(4):935-946. 10.2337/db09-0404, 2844841, 20107108.
16. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 2004, 287(1):G264-G273. 10.1152/ajpgi.00002.2004, 15044174.
17. Kiefer FW, Neschen S, Pfau B, Legerer B, Neuhofer A, Kahle M, Schlederer M, Hrabe de Angelis M, Mair M, Kenner L, et al. Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 2011, 54(8):2132-2142. 10.1007/s00125-011-2170-0, 3131508, 21562757.
18. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004, 292(8):927-934. 10.1001/jama.292.8.927, 15328324.
19. Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010, 33(11):2477-2483. 10.2337/dc10-1079, 2963518, 20693348.
20. Schulze M, Liu S, Rimm E, Manson J, Willett W, Hu F. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr 2004, 80(2):348-356.
21. Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr 2009, 89(4):1037-1042. 10.3945/ajcn.2008.27140, 2667454, 19211821.
22. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002, 75(3):492-498.
23. Stanhope K, Schwarz J, Keim N, Griffen S, Bremer A, Graham J, Hatcher B, Cox C, Dyachenko A, Zhang W, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009, 119(5):1322-1334. 10.1172/JCI37385, 2673878, 19381015.
24. Jalal DI, Smits G, Johnson RJ, Chonchol M. Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 2010, 21(9):1543-1549. 10.1681/ASN.2009111111, 3013529, 20595676.
25. Rebuffe-Scrive M, Surwit R, Feinglos M, Kuhn C, Rodin J. Regional fat distribution and metabolism in a new mouse model (C57BL/6 J) of non-insulin-dependent diabetes mellitus. Metabolism 1993, 42(11):1405-1409. 10.1016/0026-0495(93)90190-Y, 8231834.
26. Chua S, Chung W, Wu-Peng X, Zhang Y, Liu S, Tartaglia L, Leibel R. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996, 271(5251):994-996. 10.1126/science.271.5251.994, 8584938.
27. Nishina P, Naggert J, Verstuyft J, Paigen B. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metab Clin Exp 1994, 43(5):554-558. 10.1016/0026-0495(94)90195-3, 8177043.
28. Zhang S, Reddick R, Piedrahita J, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258(5081):468-471. 10.1126/science.1411543, 1411543.
29. Lichtman AH, Clinton SK, Iiyama K, Connelly PW, Libby P, Cybulsky MI. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 1999, 19(8):1938-1944. 10.1161/01.ATV.19.8.1938, 10446074.
30. Gao J, Katagiri H, Ishigaki Y, Yamada T, Ogihara T, Imai J, Uno K, Hasegawa Y, Kanzaki M, Yamamoto TT, et al. Involvement of apolipoprotein E in excess fat accumulation and insulin resistance. Diabetes 2007, 56(1):24-33. 10.2337/db06-0144, 17192461.
31. Hofmann SM, Perez-Tilve D, Greer TM, Coburn BA, Grant E, Basford JE, Tschop MH, Hui DY. Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice. Diabetes 2008, 57(1):5-12. 2830804, 17914034.
32. Bartelt A, Orlando P, Mele C, Ligresti A, Toedter K, Scheja L, Heeren J, Di Marzo V. Altered endocannabinoid signalling after a high-fat diet in Apoe (-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. Diabetologia 2011, 54(11):2900-2910. 10.1007/s00125-011-2274-6, 21847582.
33. Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 2002, 282(1):E207-E214.
34. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998, 16(7):895-906. 10.1097/00004872-199816070-00001, 9794728.
35. Neuhofer A, Zeyda M, Mascher D, Itariu BK, Murano I, Leitner L, Hochbrugger EE, Fraisl P, Cinti S, Serhan CN, et al. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes 2013, 62(6):1945-1956. 10.2337/db12-0828, 23349501.
36. Messner B, Zeller I, Ploner C, Frotschnig S, Ringer T, Steinacher-Nigisch A, Ritsch A, Laufer G, Huck C, Bernhard D. Ursolic acid causes DNA-damage, p53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo. Atherosclerosis 2011, 219(2):402-408. 10.1016/j.atherosclerosis.2011.05.025, 21703625.
37. Burger KN, Beulens JW, van der Schouw YT, Sluijs I, Spijkerman AM, Sluik D, Boeing H, Kaaks R, Teucher B, Dethlefsen C, et al. Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus. PLoS One 2012, 7(8):e43127. 10.1371/journal.pone.0043127, 3426551, 22927948.
38. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, Brand-Miller JC. Glycemic index, glycemic load, and chronic disease risk-a meta-analysis of observational studies. Am J Clin Nutr 2008, 87(3):627-637.
39. Gabrielsson BG, Wikstrom J, Jakubowicz R, Marmon SK, Carlsson NG, Jansson N, Gan LM, Undeland I, Lonn M, Holmang A, et al. Dietary herring improves plasma lipid profiles and reduces atherosclerosis in obese low-density lipoprotein receptor-deficient mice. Int J Mol Med 2012, 29(3):331-337.
40. Berg A, Scherer P. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005, 96(9):939-949. 10.1161/01.RES.0000163635.62927.34, 15890981.
41. Hartvigsen K, Binder CJ, Hansen LF, Rafia A, Juliano J, Horkko S, Steinberg D, Palinski W, Witztum JL, Li AC. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler Thromb Vasc Biol 2007, 27(4):878-885. 10.1161/01.ATV.0000258790.35810.02, 17255537.
42. Anderson K, Castelli W, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987, 257(16):2176-2180. 10.1001/jama.1987.03390160062027, 3560398.
43. Ohman MK, Shen Y, Obimba CI, Wright AP, Warnock M, Lawrence DA, Eitzman DT. Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008, 117(6):798-805. 10.1161/CIRCULATIONAHA.107.717595, 18212290.
44. Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012, 367(14):1310-1320. 3714101, 23034020.
45. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009, 373(9670):1175-1182. 10.1016/S0140-6736(09)60447-5, 19329177.
46. Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G, et al. Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 2008, 149(3):1350-1357. 10.1210/en.2007-1312, 18048491.
47. Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, Kon S, Uede T, Matsumoto T, Saito Y, Mori S. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol 2000, 20(3):624-628. 10.1161/01.ATV.20.3.624, 10712383.
48. Nilsson-Berglund L, Zetterqvist A, Nilsson-Ohman J, Sigvardsson M, González Bosc L, Smith M-L, Salehi A, Agardh E, Fredrikson G, Agardh C-D, et al. Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol 2010, 30(2):218-224. 10.1161/ATVBAHA.109.199299, 2823568, 19965778.
49. de Kleijn DP, Moll FL, Hellings WE, Ozsarlak-Sozer G, de Bruin P, Doevendans PA, Vink A, Catanzariti LM, Schoneveld AH, Algra A, et al. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010, 30(3):612-619. 10.1161/ATVBAHA.109.194944, 20018935.
50. Ludwig D. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002, 287(18):2414-2423. 10.1001/jama.287.18.2414, 11988062.
51. Li J, Wang Q, Chai W, Chen MH, Liu Z, Shi W. Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility. Cardiovasc Diabetol 2011, 10:117. 10.1186/1475-2840-10-117, 3273441, 22204493.
52. Roglans N, Vila L, Farre M, Alegret M, Sanchez RM, Vazquez-Carrera M, Laguna JC. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 2007, 45(3):778-788. 10.1002/hep.21499, 17326204.
53. Busserolles J, Rock E, Gueux E, Mazur A, Grolier P, Rayssiguier Y. Short-term consumption of a high-sucrose diet has a pro-oxidant effect in rats. Br J Nutr 2002, 87(4):337-342. 10.1079/BJN2002524, 12064343.
54. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, Cros G, Azay J. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 2005, 179(1):43-49. 10.1016/j.atherosclerosis.2004.10.018, 15721008.
55. Johnson R, Segal M, Sautin Y, Nakagawa T, Feig D, Kang D-H, Gersch M, Benner S, Sánchez-Lozada L. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007, 86(4):899-906.
56. Ushijima K, Riby JE, Fujisawa T, Kretchmer N. Absorption of fructose by isolated small intestine of rats is via a specific saturable carrier in the absence of glucose and by the disaccharidase-related transport system in the presence of glucose. J Nutr 1995, 125(8):2156-2164.
57. Merat S, Casanada F, Sutphin M, Palinski W, Reaven P. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol 1999, 19(5):1223-1230. 10.1161/01.ATV.19.5.1223, 10323773.